BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Diagnosis
81 results:

  • 1. Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations.
    Han J; Gao J; Chen D; Du M; Wu Y; Ma X; Xie M; Han H; Wu C; Xue X
    Clin Respir J; 2024 Apr; 18(4):e13750. PubMed ID: 38616354
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Application research of radiomics in colorectal cancer: A bibliometric study.
    Yang L; Wang B; Shi X; Li B; Xie J; Wang C
    Medicine (Baltimore); 2024 Apr; 103(15):e37827. PubMed ID: 38608072
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Radiation Dose Does Not Affect the Predictive Value of thyroid Biopsy for Diagnosing Papillary thyroid cancer in a Belarusian Cohort Exposed to Chernobyl Fallout.
    McConnell RJ; Kamysh O; O'Kane PL; Greenebaum E; Rozhko AV; Yauseyenka VV; Minenko VF; Drozdovitch V; Yarets Y; Kukhta T; Mabuchi K; Little MP; Cahoon EK; Zablotska LB
    Acta Cytol; 2024; 68(1):34-44. PubMed ID: 38246154
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Diagnostic Value of
    Cui B; Wu Z; Yu B; Li Y; Liu H
    Discov Med; 2023 Dec; 35(179):1064-1070. PubMed ID: 38058071
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Characterization of the thyroid cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.
    Tarasova VD; Tsai J; Masannat J; Hernandez Prera JC; Hallanger Johnson J; Veloski C; Agosto Salgado S; McIver B; Drusbosky LM; Chung CH
    Thyroid; 2024 Feb; 34(2):197-205. PubMed ID: 37962267
    [No Abstract]    [Full Text] [Related]  

  • 6. Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review.
    de Sousa MSA; Nunes IN; Christiano YP; Sisdelli L; Cerutti JM
    Rev Endocr Metab Disord; 2024 Feb; 25(1):35-51. PubMed ID: 37874477
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology.
    Wang Y; Song W; Li Y; Liu Z; Zhao K; Jia L; Wang X; Jiang R; Tian Y; He X
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16837-16850. PubMed ID: 37733241
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inflammatory myofibroblastic tumor of the thyroid gland.
    Zhang Y; Liu J
    Front Endocrinol (Lausanne); 2023; 14():1156117. PubMed ID: 37255972
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. thyroid hormones as biomarkers of lung cancer: a retrospective study.
    Ma Z; Song P; Ji D; Zheng M; Qiu G; Liu Z; Wang B
    Ann Med; 2023 Dec; 55(1):2196088. PubMed ID: 37014291
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Duodenal bleeding due to metastasis from lung adenocarcinoma controlled by radiotherapy: A case report and literature review].
    Severin S; Terrones Munoz V; Meert N; Peche R
    Rev Mal Respir; 2023 Apr; 40(4):359-365. PubMed ID: 36868976
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficacy of Immunotherapy in Second-Line Treatment of
    Knetki-Wróblewska M; Tabor S; Płużański A; Lewandowska Z; Tysarowski A; Pawlik H; Kowalski DM; Krzakowski M
    Curr Oncol; 2022 Dec; 30(1):462-475. PubMed ID: 36661686
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular testing in fine-needle aspiration of thyroid nodules.
    McMurtry V; Canberk S; Deftereos G
    Diagn Cytopathol; 2023 Jan; 51(1):36-50. PubMed ID: 36480743
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum ADAM metallopeptidase domain 12 as a promising diagnostic biomarker for breast and liver cancer.
    Wang H; Wu H; Chen Y
    Clin Transl Oncol; 2023 Feb; 25(2):473-481. PubMed ID: 36183312
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Primary pulmonary epithelial-myoepithelial carcinoma: Report of a rare and under-diagnosed low-grade malignancy.
    Sharma S; Tayal A; Khatri S; Mohapatra SG; Mohanty SK
    J Cancer Res Ther; 2022; 18(3):795-800. PubMed ID: 35900560
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Indeterminate thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
    Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
    Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of the Influence of thyroid Nodule Characteristics on the Results of Shear Wave Elastography.
    Xue JP; Kang XY; Miao JW; Zhang YX; Li HZ; Yao FC; Kang CS
    Front Endocrinol (Lausanne); 2022; 13():858565. PubMed ID: 35757426
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pulmonary inflammatory myofibroblastic tumor coexisting with lymphangitis carcinomatosis: Mimicking metastatic papillary thyroid carcinoma with nodular fasciitis-like stroma.
    Yadav SC; Kane S; Kumar R; Rekhi B
    Indian J Pathol Microbiol; 2022; 65(2):422-425. PubMed ID: 35435385
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common.
    Newfield RS; Jiang W; Sugganth DX; Hantash FM; Lee E; Newbury RO
    Int J Pediatr Otorhinolaryngol; 2022 Jun; 157():111121. PubMed ID: 35397361
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinicopathological and Molecular Features of Secondary cancer (Metastasis) to the thyroid and Advances in Management.
    Nguyen M; He G; Lam AK
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328664
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Primary Enteric Adenocarcinoma Lung with Mesenchymal Epithelial Transition Factor Amplification: A Case Report.
    Shukla S; Pandey RK; Husain N; Srivastava A
    Gulf J Oncolog; 2021 May; 1(36):76-78. PubMed ID: 35017140
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.